News Daily News FDA Approves Two Additional Indications for Rivaroxaban in Children L.A. McKeown December 21, 2021
News Daily News NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials Caitlin E. Cox February 07, 2017